Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes

Completed · Phase 3

Conditions studied: Diabetes, Gestational Diabetes

In brief

This trial is conducted in the United States of America (USA). The purpose of this study is to test whether NovoLog (insulin aspart) is a safe and at least as effective alternative to regular human insulin for the control of blood glucose after meals in women who develop diabetes during pregnancy.

Key facts

Study ID

NCT00065130

Run by

Novo Nordisk A/S

People needed

27

Starts

2000-04-01

Expected to finish

2003-12-01

Last updated by the study team

2016-12-22

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Subjects older than 35 years old will be considered
• Gestational diabetes mellitus

Where it is running

• Novo Nordisk Investigational Site — Santa Barbara, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.